Skip to main content

Advertisement

Log in

Do Endoscopic Bariatric Procedures Improve Postprocedural Quality of Life and Mental Health? A Systematic Review and Meta-analysis

  • Review
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Quality of life and mental health are important outcomes of bariatric therapy. This review aimed to determine endoscopic bariatric procedures’ impact on postprocedural quality of life and mental health. Four electronic databases were systematically searched. Studies with adults > 18 years who underwent an endoscopic bariatric procedure and reported pre- and postprocedural quality of life and/or mental health using a validated tool were included. Meta-analyses were conducted using RevMan and study quality was assessed. Twenty studies evaluating five different endoscopic procedures were included (N = 876 total sample size). Intragastric balloon placement was associated with a large improvement in postprocedural quality of life and mental health. Endoscopic bariatric therapies may improve short-term quality of life and mental health alongside weight loss and comorbidity improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

BAROS:

Bariatric Analysis and Reporting Outcome System

BQL:

body quality of life

DJBL:

duodenal-jejunal bypass liner

ESG:

endoscopic sleeve gastroplasty

EWL:

excess weight loss

FDA:

Food and Drug Administration

GIQLI:

gastrointestinal quality of life

IGB:

intragastric balloon

OR:

Odds Ratio

POSE:

primary obesity surgery and endoluminal

QoL:

quality of life

SF-36:

Short Form Health Survey

SMD:

standardised mean difference

TPS:

transpyloric shuttle

References

  1. World Health Organization. Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Published 2018. Acessed November 11, 2019.

  2. Guedes E et al. Impact of 6 months of treatment with intragastric balloon on body fat and quality of life in obese individuals with metabolic syndrome. Health Qual Life Outcomes. 2017;15(1):1–6.

    Google Scholar 

  3. Sierżantowicz R, Lewko J, Razak Hady H, et al. Effect of BMI on quality of life and depression levels after bariatric surgery. Adv Clin Exp Med : official organ Wroclaw Medical University. 2017;26(3):491–6.

    Google Scholar 

  4. Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94.

    PubMed  Google Scholar 

  5. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. Jama-J Am Med Assoc. 2004;292(14):1724–37.

    CAS  Google Scholar 

  6. Regan J et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13(6):861–4.

    CAS  PubMed  Google Scholar 

  7. Schwartz A, Etchechoury L, Collet D. Outcome after laparoscopic gastric bypass for super-super obese patients. J Visceral Surg. 2013;150(2):145–9.

    CAS  Google Scholar 

  8. Villamere J, Gebhart A, Vu S, et al. Body mass index is predictive of higher in-hospital mortality in patients undergoing laparoscopic gastric bypass but not laparoscopic sleeve gastrectomy or gastric banding. Am Surg. 2014;80(10):1039–43.

    PubMed  Google Scholar 

  9. Behary J, Kumbhari V. Advances in the endoscopic management of obesity. Gastroenterol Res Pract. 2015;2015:1–9.

    Google Scholar 

  10. Abu Dayyeh BK et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–38.e5.

    PubMed  Google Scholar 

  11. FDA (Food and Drug Administration). Weight-loss and weight management devices. 2019 [cited 2020 11-03]; Available from: https://www.fda.gov/medical-devices/products-and-medical-procedures/weight-loss-and-weight-management-devices#loss. Accessed 16 Sept 2019.

  12. Familiari P, Costamagna G, Bléro D, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc. 2011;74(6):1248–58.

    PubMed  Google Scholar 

  13. Fiorillo C, Quero G, Vix M, et al. 6-month gastrointestinal quality of life (QoL) results after endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a propensity score analysis. Obes Surg. 2020;30:1944–51.

    PubMed  Google Scholar 

  14. Jason B and Vivek K, Advances in the endoscopic management of obesity. Gastroenterol Res Pract, 2015. 2015(2015).

  15. Saber AA, Shoar S, Almadani MW, et al. Efficacy of first-time intragastric balloon in weight loss: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2017;27(2):277–87.

    PubMed  Google Scholar 

  16. Spirou D, Raman J, Smith E. Psychological outcomes following surgical and endoscopic bariatric procedures: a systematic review. Obes Rev. 2020;21:e12998.

    PubMed  Google Scholar 

  17. Yorke E, Switzer NJ, Reso A, et al. Intragastric balloon for management of severe obesity: a systematic review. Obes Surg. 2016;26(9):2248–54.

    PubMed  Google Scholar 

  18. Fernandes MAP, et al., Intragastric balloon for obesity. Cochrane Database Syst Rev, 2007(1).

  19. Szmulewicz A, Wanis KN, Gripper A, et al. Mental health quality of life after bariatric surgery: a systematic review and meta-analysis of randomized clinical trials. Clinical obesity. 2019;9(1):e12290.

    PubMed  Google Scholar 

  20. Mui W et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20(8):1128–32.

    PubMed  Google Scholar 

  21. NCE (National Institute for Health and Care Excellence) Obesity: identification, assessment and management. 2014.

  22. Accardi R, Ronchi S, Racaniello E, et al. Italian version of the Laval questionnaire: validity and reliability. Bariatric Surg Pract Patient Care. 2017;12(3):136–41.

    Google Scholar 

  23. Moher D et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264.

    PubMed  Google Scholar 

  24. Google. Google Translate. Available from: https://translate.google.com/. Acessed November 11, 2019.

  25. Bond University. Systematic Review Accelerator.; Available from: http://sr-accelerator.com/#/. Accessed November 11, 2019.

  26. EndNote [computer program]. Version X8, Web of Science Group. 2019.

  27. Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org. Accessed 20 July 2019.

  28. PLOTCON, WebplotDigitizer. 2017: Oakland, CA.

  29. Academy of Nutrition & Dietetics. Evidence Analysis Manual. Appendix 8: Quality Criteria Checklist: Primary Research Available from: https://www.andeal.org/evidence-analysis-manual Published 2016. Accessed October 28, 2019

  30. Erika Paniago G et al. Impact of 6 months of treatment with intragastric balloon on body fat and quality of life in obese individuals with metabolic syndrome. Health Qual Life Outcomes. 2017;15(1):1–6.

    Google Scholar 

  31. The Cochrane Collaboration, Review Manager [computer program]. Version 5.3. 2014: Copenhagen: The Nordic Cochrane Centre

  32. Higgins JPT. Cochrane handbook for systematic reviews of interventions. In: Thomas J, editor. Wiley Cochrane Ser. 2nd ed. Newark: John Wiley & Sons, Incorporated; 2019.

    Google Scholar 

  33. Tayyem RM, Obondo C, Ali A. Short-term outcome and quality of life of endoscopically placed gastric balloon and laparoscopic adjustable gastric band. Saudi J Gastroenterol : official journal of the Saudi Gastroenterology Association. 2011;17(6):400–5.

    Google Scholar 

  34. Tayyem RM, Atkinson JM, Martin CR. Development and validation of a new bariatric-specific health-related quality of life instrument “bariatric and obesity-specific survey (BOSS)”. J Postgrad Med. 2014;60(4):357–61.

    CAS  PubMed  Google Scholar 

  35. Guedes E et al. Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome. Diabetol Metab Syndr. 2016;8(1):1–7.

    Google Scholar 

  36. Raftopoulos I, Giannakou A. The Elipse Balloon, a swallowable gastric balloon for weight loss not requiring sedation, anesthesia or endoscopy: a pilot study with 12-month outcomes. Surg Obes Relat Dis. 2017;13(7):1174–82.

    PubMed  Google Scholar 

  37. Reimão S et al. Improvement of body composition and quality of life following intragastric balloon. Obes Surg. 2018;28(6):1806–8.

    PubMed  Google Scholar 

  38. Ponce J, Quebbemann BB, Patterson EJ. Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity. Surg Obes Relat Dis. 2013;9(2):290–5.

    PubMed  Google Scholar 

  39. Machytka E, Gaur S, Chuttani R, et al. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. Endoscopy. 2017;49(2):154–60.

    PubMed  Google Scholar 

  40. Guedes MR, Fittipaldi-Fernandez RJ, Diestel CF, et al. Changes in body adiposity, dietary intake, physical activity and quality of life of obese individuals submitted to intragastric balloon therapy for 6 months. Obes Surg. 2019;29(3):843–50.

    PubMed  Google Scholar 

  41. Alfredo G, Roberta M, Massimiliano C, et al. Long-term multiple intragastric balloon treatment—a new strategy to treat morbid obese patients refusing surgery: prospective 6-year follow-up study. Surg Obes Relat Dis. 2014;10(2):307–11.

    PubMed  Google Scholar 

  42. Fuller N et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study. Obesity. 2013;21(8):1561–70.

    PubMed  Google Scholar 

  43. Deliopoulou K, Konsta A, Penna S, et al. The impact of weight loss on depression status in obese individuals subjected to intragastric balloon treatment. Obes Surg. 2013;23(5):669–75.

    PubMed  Google Scholar 

  44. Castro M et al. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg. 2010;20(12):1642–6.

    PubMed  Google Scholar 

  45. Ahmed HO, Ezzat RF. Quality of life of obese patients after treatment with the insertion of intra-gastric balloon versus Atkins diet in Sulaimani Governorate, Kurdistan Region, Iraq. Ann Med Surg (2012). 2018;37:42–6.

    Google Scholar 

  46. Christopher CT et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol. 2016;112(3):447–57.

    Google Scholar 

  47. Norén E, Forssell H. Aspiration therapy for obesity; a safe and effective treatment. BMC Obesity. 2016;3(1):56.

    PubMed  PubMed Central  Google Scholar 

  48. Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy. 2008;40(5):406–13.

    CAS  PubMed  Google Scholar 

  49. Marinos G, Eliades C, Raman Muthusamy V, et al. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis. 2014;10(5):929–34.

    PubMed  Google Scholar 

  50. Lindekilde N et al. The impact of bariatric surgery on quality of life: a systematic review and meta-analysis. Obes Rev. 2015:16, 639–651.

  51. Dawes AJ, Maggard-Gibbons M, Maher AR, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA. 2016;315(2):150–63.

    CAS  PubMed  Google Scholar 

  52. Canetti L, Bachar E, Bonne O. Deterioration of mental health in bariatric surgery after 10 years despite successful weight loss. Eur J Clin Nutr. 2016;70(1):17–22.

    CAS  PubMed  Google Scholar 

  53. Marshall S, et al., Does intensive multidisciplinary intervention for adults who elect bariatric surgery improve postoperative weight loss, comorbidities, and quality of life? A systematic review and meta-analysis Obesity Reviews, 2020. In Press.

  54. Mechanick JI, et al., Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures–2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surgery for Obesity and Related Diseases, 2019.

  55. Cuijpers P, Weitz E, Cristea IA, et al. Pre-post effect sizes should be avoided in meta-analyses. Epidemiol Psychiatric Sci. 2017;26(4):364–8.

    CAS  Google Scholar 

  56. Von Elm E et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007;45(4):247–51.

    Google Scholar 

  57. Allergan. Intragastric Balloon System—Directions For Use (DFU). 2011; Available from: http://www.allergan.com.au/Products/Overview.aspx. Accessed 25 Mar 2020.

  58. Beck AT et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561.

    CAS  PubMed  Google Scholar 

  59. Beck AT, Steer RA, and Brown GK, Beck Depression Inventory - Second Edition (BDI-II). 1996.

  60. EuroQol Research Foundation. EQ-5D-5L User Guide. 2019 [cited 2020 10.02]; Available from: https://euroqol.org/publications/user-guides.

  61. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995;82(2):216–22.

    CAS  PubMed  Google Scholar 

  62. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    CAS  PubMed  Google Scholar 

  63. Organization, W.H. WHO Quality of Life-BREF (WHOQOL-BREF). n.d; Available from: https://www.who.int/substance_abuse/research_tools/whoqolbref/en/. Accessed 23 Jan 2020.

  64. Kolotkin, R. IWQOL-Lite Assessing the impact of weight on quality of life in adults. 2017; Available from: https://www.qualityoflifeconsulting.com/iwqol-lite.html. Accessed 15 Feb 2020.

  65. Kolotkin RL, Head S, Brookhart A. Construct validity of the impact of weight on quality of life questionnaire. Obes Res. 1997;5:434–41.

    CAS  PubMed  Google Scholar 

  66. Ware JE, Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.

    PubMed  Google Scholar 

  67. John E. Ware et al. SF-36 Health Survey Manual and Interpretation Guide. 1993.

Download references

Acknowledgements

The authors acknowledge the contributions of Bronwyn Linthwaite, Bond University Librarian, for her assistance with the search strategy.

Funding

This review has received no specific funding. SM is supported by a Commonwealth of Australia Innovation Connections grant.

Author information

Authors and Affiliations

Authors

Contributions

NG and AM drafted the manuscript and led the search, data extraction, critical appraisals, meta-analysis, and GRADE assessment. JH, BFK, and IM contributed to data checking and critical appraisals. SM contributed to critical appraisals, meta-analysis, and GRADE assessment. All authors contributed to study concept and manuscript revision.

Corresponding author

Correspondence to Skye Marshall.

Ethics declarations

Conflict of Interest

The authors declare that there are no conflicts of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Informed consent does not apply.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(DOCX 66 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gadd, N., McIntosh, A., Fear-Keen, B. et al. Do Endoscopic Bariatric Procedures Improve Postprocedural Quality of Life and Mental Health? A Systematic Review and Meta-analysis. OBES SURG 30, 4091–4100 (2020). https://doi.org/10.1007/s11695-020-04860-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-020-04860-2

Keywords

Navigation